Quest Diagnostics Windsor Locks

Quest Diagnostics empowers people to take action to improve health outcomes. The company was founded in April 1967 as Metropolitan Pathology Laboratory, Inc. Corning Glass Works acquired the company in 1982 and later spun it off as a publicly traded company under the name Quest Diagnostics, at the beginning of 1997. Quest has developed countless innovative diagnostic information services, with several firsts for clinical laboratory tests in areas such as women's health, genetics, infectious diseases and cancer. Today, Quest provides thousands of laboratory services, from genetic tests to predict cancer risk to biological tests for diabetes and heart disease, to empower people to take action to improve health outcomes. One in three American adults and one in two physicians and hospitals use the company's services each year, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.